Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    18287387 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Apatinib
2 Recruiting Nephron Sparing Renal Surgery and Total Nephrectomy
Condition: Kidney Diseases
Intervention:
3 Unknown  Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent;   No EGFR Activating Mutation
Interventions: Radiation: 18F-FLT-TEP;   Radiation: 18F-FDG-TEP
4 Terminated F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer
Condition: Castration-resistant Prostate Cancer
Intervention: Device: F-Choline-PET
5 Completed EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration
Conditions: Pancreas Adenocarcinoma;   Pancreas Neoplasms;   Gastrointestinal Stromal Tumor;   Lymphoma
Interventions: Device: Fine needle biopsy using ProCore needle for histology.;   Device: Fine needle aspiration using conventional FNA for cytology
6 Terminated
Has Results
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Conditions: Multiple Myeloma;   Leukemia, Plasma Cell
Interventions: Drug: Carfilzomib;   Drug: Melphalan;   Drug: Filgrastim
7 Completed Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study
Condition: Epithelial Ovarian Cancer
Intervention: Biological: MUC1 Dendritic Cell Vaccine (Cvac)
8 Active, not recruiting Collection of Transplant Stem Cells for Plasma Cell Myeloma
Conditions: Plasma Cell Myeloma;   Multiple Myeloma
Interventions: Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Apheresis
9 Unknown  INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER
Condition: Head and Neck Cancer
Interventions: Radiation: Radiotherapy;   Drug: Leucovorin;   Biological: Cetuximab;   Drug: Filgrastim;   Drug: Erythropoetin;   Drug: Cisplatin;   Drug: Fluorouracil;   Drug: Docetaxel
10 Active, not recruiting
Has Results
Proton Therapy for Lymph Nodes in Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: Photon;   Radiation: 3D-Proton/Conventional plan or 3D-proton only
11 Completed
Has Results
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase
12 Recruiting Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Procedure: Adoptive Immunotherapy;   Biological: Rapamycin-Generated Autologous Th1/Tc1 Cells
13 Completed Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Sirolimus
14 Completed
Has Results
Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
Conditions: Squamous Cell Carcinoma of Mouth;   Intraepithelial Neoplasia
Interventions: Drug: 10% FBR containing bioadhesive gel;   Drug: placebo gel
15 Withdrawn Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Conditions: Colorectal Carcinoma;   Peritoneal Carcinomatosis
Intervention: Procedure: Laparotomy+ HIPEC +/- CRS
16 Completed
Has Results
Ovarian Cancer Vaccine for Patients in Remission
Condition: Epithelial Ovarian Cancer
Intervention: Biological: Cvac
17 Completed A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Human Papillomavirus
Intervention:
18 Recruiting A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Conditions: Head and Neck Neoplasms;   Lung Neoplasms;   Urinary Bladder Neoplasms;   Breast Neoplasms
Interventions: Drug: 5-Fluoro-2-Deoxycytidine (FdCyd);   Drug: Tetrahydrouridine (THU)
19 Active, not recruiting Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small-Cell Lung
Intervention:
20 Completed Anal Cancer Screening Study
Condition: Anal Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years